SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-128786
Filing Date
2018-04-24
Accepted
2018-04-24 16:09:57
Documents
11
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d499417ddefa14a.htm DEFA14A 57023
2 GRAPHIC g499417aa1.jpg GRAPHIC 35028
3 GRAPHIC g499417aa100.jpg GRAPHIC 2336
4 GRAPHIC g499417aa2.jpg GRAPHIC 4836
5 GRAPHIC g499417aa3.jpg GRAPHIC 6277
6 GRAPHIC g499417aa4.jpg GRAPHIC 3716
7 GRAPHIC g499417aa6.jpg GRAPHIC 2328
8 GRAPHIC g499417aa7.jpg GRAPHIC 5425
9 GRAPHIC g499417aa7a.jpg GRAPHIC 7447
10 GRAPHIC g499417aa8.jpg GRAPHIC 10441
11 GRAPHIC g499417aa9.jpg GRAPHIC 2326
  Complete submission text file 0001193125-18-128786.txt   169547
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33451 | Film No.: 18771537
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1